Efficacy and safety of apatinib combined with transarterial chemoembolization (TACE) in treating patients with recurrent hepatocellular carcinoma

BACKGROUND: Apatinib, a vascular endothelial growth factor receptor 2 (VEGFR-2) inhibitor, has shown promising therapeutic effect for hepatocellular carcinoma (HCC). This prospective clinical study was implemented to evaluate the efficacy and safety of apatinib combined with transarterial chemoembol...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Ann Transl Med
Main Authors: Gu, Huiying, Li, Jing, You, Nan, Wu, Ke, Wang, Zheng, Wang, Liang, Zhu, Yinan, Liu, Qinqin, Peng, Xuehui, Zheng, Lu
Format: Artigo
Sprog:Inglês
Udgivet: AME Publishing Company 2020
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7812192/
https://ncbi.nlm.nih.gov/pubmed/33490189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-7244
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker